X-Linked Adrenoleukodystrophy (X-ALD)

Abnormal Newborn Screening Results and Additional Testing

If your baby’s newborn screening results are abnormal, your baby may need to have another test to confirm the result. It is important to have quick follow-up testing. The Utah Newborn Screening Program will contact you and your child’s pediatrician with follow-up recommendations.

The Neurology Clinic at Primary Children’s Hospital cares for babies diagnosed with X-ALD.

About X-ALD

X-Linked Adrenoleukodystrophy (X-ALD) is a disorder that affects adrenal function and the brain and spinal cord’s dyemylination. This disorder primarily affects males, but can also affect females to a lesser extent. Boys develop normally until symptoms show around the age of 4 to 10, which is too late to prevent disability or death. Treatments are available that can improve quality of life if diagnosed early.

Types of X-ALD

  • A childhood cerebral form primarily in males.
  • Adrenomyelnoneuroapthy (AMN)
  • Addison-only Disease

Frequency

X-ALD affects approximately 1 in 17,000 individuals in the United States.

Condition Type

X-ALD is a Neuromuscular Disorder.

Also Known As

Adrenomyeloneuropathy, Adrenomyeloneuropathy (AMN), ALD, AMN, C26:0, X-ALD, X-Linked Adrenoleukodystophy, X-Linked Adrenoleukodystrophy (ALD)